Author:
Tian Jing,Yan Jingjing,Han Gangfei,Du Yutao,Hu Xiaojuan,He Zixuan,Han Qinghua,Zhang Yanbo
Abstract
Abstract
Background
Patient-reported outcomes (PROs) can be obtained outside hospitals and are of great significance for evaluation of patients with chronic heart failure (CHF). The aim of this study was to establish a prediction model using PROs for out-of-hospital patients.
Methods
CHF-PRO were collected in 941 patients with CHF from a prospective cohort. Primary endpoints were all-cause mortality, HF hospitalization, and major adverse cardiovascular events (MACEs). To establish prognosis models during the two years follow-up, six machine learning methods were used, including logistic regression, random forest classifier, extreme gradient boosting (XGBoost), light gradient boosting machine, naive bayes, and multilayer perceptron. Models were established in four steps, namely, using general information as predictors, using four domains of CHF-PRO, using both of them and adjusting the parameters. The discrimination and calibration were then estimated. Further analyze were performed for the best model. The top prediction variables were further assessed. The Shapley additive explanations (SHAP) method was used to explain black boxes of the models. Moreover, a self-made web-based risk calculator was established to facilitate the clinical application.
Results
CHF-PRO showed strong prediction value and improved the performance of the models. Among the approaches, XGBoost of the parameter adjustment model had the highest prediction performance with an area under the curve of 0.754 (95% CI: 0.737 to 0.761) for death, 0.718 (95% CI: 0.717 to 0.721) for HF rehospitalization and 0.670 (95% CI: 0.595 to 0.710) for MACEs. The four domains of CHF-PRO, especially the physical domain, showed the most significant impact on the prediction of outcomes.
Conclusion
CHF-PRO showed strong prediction value in the models. The XGBoost models using variables based on CHF-PRO and the patient’s general information provide prognostic assessment for patients with CHF. The self-made web-based risk calculator can be conveniently used to predict the prognosis for patients after discharge.
Clinical Trial Registration
URL: http://www.chictr.org.cn/index.aspx; Unique identifier: ChiCTR2100043337.
Graphical abstract
Funder
National Natural Science Foundation of China
Shanxi Provincial Key Research and Development Project
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,General Medicine
Reference32 articles.
1. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599–726.
2. The Writing Committee of the Report on. Cardiovascular Health and Diseases in China, Report on Cardiovascular Health and Diseases in China 2019: an updated Summary. Chin Circulation J. 2020;35:833–54.
3. Rahimi K, Bennett D, Conrad N, Williams TM, Basu J, Dwight J, et al. Risk prediction in patients with heart failure: a systematic review and analysis. JACC Heart Fail. 2014;2:440–6.
4. Gottdiener JS, Fohner AE. Risk prediction in Heart failure: new methods, old problems. JACC Heart Fail. 2020;8:22–4.
5. U.S. Department of Health and Human Services, FDA, Center for Drug Evaluation and Research., Center for Biologics Evaluation and Research, Center for Devices and Radiological Health. Guidance for Industry-Patient Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. 2009; 12.